Joseph Fitzgerald
Corporate Officer/Principal bei BOSTON SCIENTIFIC CORPORATION
Vermögen: 14 Mio $ am 30.04.2024
Profil
Joseph M.
Fitzgerald is currently the President-Interventional Cardiology & Executive VP at Boston Scientific Corp.
He previously worked as the Director-Business Intelligence at Anheuser Busch, Inc., the President at CryoCor, Inc., and the Vice President-Global Marketing at NeuroVascular Recovery Ltd.
Mr. Fitzgerald completed his undergraduate degree at Indiana University and holds an MBA from Southern Illinois University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 13.05.2024 | 195 381 ( 0,01% ) | 14 Mio $ | 30.04.2024 |
Aktive Positionen von Joseph Fitzgerald
| Unternehmen | Position | Beginn |
|---|---|---|
| BOSTON SCIENTIFIC CORPORATION | Corporate Officer/Principal | 11.02.2010 |
Ehemalige bekannte Positionen von Joseph Fitzgerald
| Unternehmen | Position | Ende |
|---|---|---|
NeuroVascular Recovery Ltd.
 NeuroVascular Recovery Ltd. Miscellaneous Commercial ServicesCommercial Services NeuroVascular Recovery Ltd. develops composite tissue implants. | Vertrieb & Marketing | - |
Anheuser Busch, Inc.
 Anheuser Busch, Inc. Beverages: AlcoholicConsumer Non-Durables Anheuser Busch, Inc. produced, distributed, and sold beer, soft drinks, and other non-alcoholic and non-carbonated products. It used to manufacture and recycle aluminum cans. The company was founded in 1957 and was headquartered in St. Louis, MO. | Corporate Officer/Principal | - |
CryoCor, Inc.
 CryoCor, Inc. Medical SpecialtiesHealth Technology CryoCor, Inc. provided medical technology services. It developed and manufactured a disposable catheter system based on its proprietary cryoablation technology for the minimally invasive treatment of cardiac arrhythmias. The firm's product the CryoCor Cardiac Cryoablation System, was designed to treat cardiac arrhythmias through the use of cryoenergy, or extreme cold, to destroy targeted cardiac tissue. The company was founded in 2000 and was headquartered in San Diego, CA. | Präsident | - |
Ausbildung von Joseph Fitzgerald
| Indiana University | Undergraduate Degree |
| Southern Illinois University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BOSTON SCIENTIFIC CORPORATION | Health Technology |
| Private Unternehmen | 3 |
|---|---|
CryoCor, Inc.
CryoCor, Inc. Medical SpecialtiesHealth Technology CryoCor, Inc. provided medical technology services. It developed and manufactured a disposable catheter system based on its proprietary cryoablation technology for the minimally invasive treatment of cardiac arrhythmias. The firm's product the CryoCor Cardiac Cryoablation System, was designed to treat cardiac arrhythmias through the use of cryoenergy, or extreme cold, to destroy targeted cardiac tissue. The company was founded in 2000 and was headquartered in San Diego, CA. | Health Technology |
Anheuser Busch, Inc.
Anheuser Busch, Inc. Beverages: AlcoholicConsumer Non-Durables Anheuser Busch, Inc. produced, distributed, and sold beer, soft drinks, and other non-alcoholic and non-carbonated products. It used to manufacture and recycle aluminum cans. The company was founded in 1957 and was headquartered in St. Louis, MO. | Consumer Non-Durables |
NeuroVascular Recovery Ltd.
NeuroVascular Recovery Ltd. Miscellaneous Commercial ServicesCommercial Services NeuroVascular Recovery Ltd. develops composite tissue implants. | Commercial Services |
